SRZN
Surrozen IncNASDAQ
Healthcare • Biotechnology
$31.00+6.90%
Close Nov 6, 2026
- Market cap
- —
- 1 month
- +10.8%
- 3 months
- +23.6%
- 1 year
- +149.6%
- 52-week range
- $11.80$34.13
- Dividend
- No dividends on record
- Next-quarter EPS estimate
- -$1.32Quarter to Sep 30, 2026 · 3 analysts · revenue $380K · 0.0% in 30d
- Short interest
- 83.8% of float3.1M shares · settled Oct 15, 2026 · +43.0% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $11.51M
- Net income
- -$332.13M
- Free cash flow
- -$34.98M
- Book value
- —
- Total debt
- $6.32M
- P/E
- —
- Price / sales
- —
- Price / book
- —
- FCF yield
- —
- Net margin
- -2,885.3%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Surrozen Inc
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system.
Read more
The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
- Website
- surrozen.com
- Headquarters
- South San Francisco, CA, United States
- Employees
- 44
- Listed
- Jan 11, 2021
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 24, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 6, 2026 | $5.0M | +408.6% | 100.0% | -$10.4M | $50.2M |
| Mar 2026filed May 6, 2026 | $5.0M | +408.6% | 98.7% | -$10.5M | -$127.5M |
| Dec 2025filed Mar 23, 2026 | $528.0K | -19.4% | — | -$12.6M | -$183.2M |
| Sep 2025filed Nov 7, 2025 | $983.0K | — | 100.0% | -$10.9M | -$71.6M |
| Jun 2025filed Aug 8, 2025 | $983.0K | — | — | -$9.0M | $39.7M |
| Mar 2025filed May 9, 2025 | $983.0K | -76.3% | 100.0% | -$9.6M | -$27.0M |
| Dec 2024filed Mar 31, 2025 | $655.0K | — | — | -$8.6M | -$28.0M |
| Sep 2024filed Nov 6, 2024 | — | — | — | — | — |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched SRZN. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
3,131,276 shares short
+941,516 shares (+43%) vs Sep 30, 2026
83.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,189,760 shares short
-5,745 shares (-0.3%) vs Sep 15, 2026
47.4% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,195,505 shares short
+750,014 shares (+51.9%) vs Aug 31, 2026
46.9% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,445,491 shares short
+192,351 shares (+15.3%) vs Aug 14, 2026
30.9% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
1,253,140 shares short
+102,753 shares (+8.9%) vs Jul 31, 2026
26.8% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
1,150,387 shares short
+179,430 shares (+18.5%) vs Jul 15, 2026
24.6% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind SRZN’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 15 · reverse split
Effective Dec 14, 2023
Each 15 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if SRZN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: HIGH
20 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
69 filers reported a long position in SRZN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
66.5%
of the 10.3M shares 13-F filers reported
Moves vs Q1 2026
5 added1 trimmed
1 new · 3 unchanged
Net shares held
+24.7%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | TCG Crossover Management, LLC | $38.2M · 1.5M shares | 1.5M | Unchanged |
| 2 | Boxer Capital Management, LLC | $27M · 1.1M shares | 1.1M | +44.3% |
| 3 | MILLENNIUM MANAGEMENT LLC | $17.7M · 683.1K shares | 683.1K | -6.6% |
| 4 | Point72 Asset Management, L.P. | $17.2M · 664.3K shares | 664.3K | New |
| 5 | Venrock Adviser, LLC | $16.4M · 632.9K shares | 632.9K | Unchanged |
| 6 | STEMPOINT CAPITAL LP | $13.8M · 602.8K shares | 602.8K | +14.7% |
| 7 | PERCEPTIVE ADVISORS LLC | $13.1M · 504K shares | 504K | +119.7% |
| 8 | Spruce Street Capital LP | $11.2M · 432K shares | 432K | Unchanged |
| 9 | BlackRock, Inc. | $10.2M · 394.9K shares | 394.9K | +1,317.8% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | $10.2M · 392.6K shares | 392.6K | +132.2% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of SRZN file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 6, 2026 | COLUMN GROUP III GP LP13D · activist · amended | 21.4% |
| Oct 7, 2026 | Boxer Capital Management, LLC13G · passive · amended | 11.6% |
| Oct 1, 2026 | Commodore Capital LP13G · passive | 7.5% |
| Aug 14, 2026 | STEMPOINT CAPITAL LP13G · passive | 5% |
| Aug 14, 2026 | BRAIDWELL LP13G · passive · amended | 3.9%under 5% |
| Aug 11, 2026 | 5AM Partners VII LLC13G · passive · amended | 7.8% |
| Jul 24, 2026 | TCG Crossover GP II LLC13G · passive · amended | 9.9% |
| May 15, 2026 | Venrock Healthcare Capital Partners III LP13G · passive · amended | 9.9% |
| May 15, 2026 | Nantahala Capital Management, LLC13G · passive · amended | 2.14%under 5% |
| Apr 23, 2026 | Point72 Asset Management, L.P.13G · passive | 5.4% |
Get the Full Analysis for SRZN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.